# Combination of CT and Ultrasound Radiomics Combined With Liquid Biopsy to Predict Neoadjuvant Chemotherapy Response in Patients With Locally Advanced Gastric Cancer

> **NCT07697079** · — · NOT_YET_RECRUITING · sponsor: **Liu Yang** · enrollment: 300 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07697079
- **Lead sponsor:** Liu Yang
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-02-01
- **Primary completion:** 2029-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07697079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07697079, "Combination of CT and Ultrasound Radiomics Combined With Liquid Biopsy to Predict Neoadjuvant Chemotherapy Response in Patients With Locally Advanced Gastric Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07697079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*